What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Disease
- Antibiotics
Anne Schuchat spends much of her time researching Group B, Epidemiology, Pediatrics, Incidence and Immunology.
The Group B study combines topics in areas such as Bacteremia, Disease, Public health and Streptococcal disease.
Anne Schuchat interconnects Transmission, Environmental health and Risk factor in the investigation of issues within Epidemiology.
Her work carried out in the field of Pediatrics brings together such families of science as Cohort study, Chemoprophylaxis, Retrospective cohort study, Mass screening and Group B Streptococcal Infection.
Her Immunology study combines topics in areas such as Internal medicine and Streptococcus pneumoniae.
In her research, Vaccination is intimately related to Heptavalent Pneumococcal Conjugate Vaccine, which falls under the overarching field of Internal medicine.
Her most cited work include:
- Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. (2163 citations)
- Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine (1950 citations)
- Bacterial Meningitis in the United States in 1995 (1140 citations)
What are the main themes of her work throughout her whole career to date?
Anne Schuchat mainly focuses on Pediatrics, Group B, Immunology, Epidemiology and Internal medicine.
Her Pediatrics research is multidisciplinary, incorporating elements of Antibiotics, Incidence, Group B Streptococcal Infection and Risk factor.
Her Group B research is multidisciplinary, incorporating perspectives in Antibiotic prophylaxis, Neonatal sepsis, Streptococcal disease, Disease and Obstetrics.
In her work, Pneumonia and Antibiotic resistance is strongly intertwined with Streptococcus pneumoniae, which is a subfield of Immunology.
The study incorporates disciplines such as Surgery and Public health in addition to Epidemiology.
The various areas that she examines in her Internal medicine study include Penicillin, Serotype, Antibacterial agent and Drug resistance.
She most often published in these fields:
- Pediatrics (34.65%)
- Group B (31.58%)
- Immunology (24.56%)
What were the highlights of her more recent work (between 2009-2021)?
- Immunology (24.56%)
- Vaccination (13.60%)
- Public health (11.40%)
In recent papers she was focusing on the following fields of study:
Anne Schuchat mainly investigates Immunology, Vaccination, Public health, Immunization and Family medicine.
Her Immunology research incorporates themes from Pneumococcal conjugate vaccine, Streptococcus pneumoniae, Pediatrics and Intensive care medicine.
Her research investigates the connection between Pneumococcal conjugate vaccine and topics such as Group B that intersect with issues in Microbiology.
Her studies in Pediatrics integrate themes in fields like Antibiotic prophylaxis, Incidence, Group B Streptococcal Infection, Group B Streptococcus Screening and Prenatal care.
Her research in Public health intersects with topics in Pandemic, Disease, Outbreak and Infection control.
Her Family medicine study deals with Epidemiology intersecting with Middle East respiratory syndrome coronavirus.
Between 2009 and 2021, her most popular works were:
- Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. (2163 citations)
- COVID-19: towards controlling of a pandemic. (591 citations)
- Bacterial Meningitis in the United States, 1998-2007 (574 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Antibiotics
Her primary areas of investigation include Vaccination, Immunology, Family medicine, Environmental health and Pediatrics.
The concepts of her Vaccination study are interwoven with issues in Immunization and Reactogenicity.
Her Immunology study incorporates themes from Developing country and Pneumococcal conjugate vaccine, Streptococcus pneumoniae.
Her Streptococcus pneumoniae research incorporates elements of Haemophilus influenzae and Group B.
Her studies deal with areas such as Chemoprophylaxis, Neonatal sepsis, Group B Streptococcal Infection and Mass screening as well as Pediatrics.
Her research combines Incidence and Conjugate vaccine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
